Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic

• DOI: 10.20944/preprints202308.1245.v1
• Publication Date: 2023-08-18T07:51:45Z
• Authors: Piotr Rzymski; Maria Pokorska-Śp...; Teresa Jackowska; Ernest Kuchar; Aneta Nitsch-Osuch; Małgorzata Pawłowska; Mateusz Babicki; Jerzy Jaroszewicz; Leszek Szenborn; Jacek Wysocki; Robert Flisiak
• Keywords: Pandemic

The COVID-19 pandemic has been met with an unprecedented response from the scientific community leading to development, study, and authorization of vaccines antivirals, ultimately reducing impact SARS-CoV-2 on global public health. However, is far being eradicated, continues evolve, causes substantial health economic burdens. In this paper, we posit essential points its management during transition acute phase pandemic. As discussed, despite Omicron (sub)variant(s) causing clinically milder infections, a negligible pathogen. It requires continued genomic surveillance, particularly if one considers that future (sub)lineages do not necessarily have be milder. Antivirals remain elements in management. former could benefit further development improvements dosing, while seasonal administration latter simplification increase interest tackle vaccine hesitancy. also ensure accessibility pharmaceuticals low-income countries improve understanding their use context long-term goals Regardless location, primary role awareness education must played by healthcare workers who directly communicate patients serve as models for healthy behaviors.